Cargando…
Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial
Venous thromboembolism (VTE) is a frequent complication of cancer associated with morbidity, mortality, increased hospitalizations and higher health care costs. Cancer patients at increased risk for VTE can be identified using a validated risk assessment score, and the incidence of VTE can be reduce...
Autores principales: | Khorana, Alok A., Vadhan-Raj, Saroj, Kuderer, Nicole M., Wun, Ted, Liebman, Howard, Soff, Gerald, Belani, Chandra, O'Reilly, Eileen M., McBane, Robert, Eikelboom, John, Damaraju, C.V, Beyers, Karen, Dietrich, Flavia, Kakkar, Ajay K., Riess, Hanno, Peixoto, Renata D'Alpino, Lyman, Gary H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Schattauer GmbH
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328370/ https://www.ncbi.nlm.nih.gov/pubmed/28933799 http://dx.doi.org/10.1160/TH17-03-0171 |
Ejemplares similares
-
Rivaroxaban thromboprophylaxis for gastric/gastroesophageal junction tumors versus other tumors: A post hoc analysis of the randomized CASSINI trial
por: Mones, Jodi V., et al.
Publicado: (2021) -
Assessing Full Benefit of Rivaroxaban Prophylaxis in High-Risk Ambulatory Patients with Cancer: Thromboembolic Events in the Randomized CASSINI Trial
por: Khorana, Alok A., et al.
Publicado: (2020) -
Rivaroxaban thromboprophylaxis in ambulatory patients with pancreatic cancer: Results from a pre‐specified subgroup analysis of the randomized CASSINI study
por: Vadhan‐Raj, Saroj, et al.
Publicado: (2020) -
Biomarker signatures in cancer patients with and without venous thromboembolism events: a substudy of CASSINI
por: Khorana, Alok A., et al.
Publicado: (2022) -
Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
por: Bauersachs, Rupert, et al.
Publicado: (2020)